ZYBT
Zhengye Biotechnology Holding Limited Ordinary Shares
ZYBT
ZYBT
3 hedge funds and large institutions have $7.19K invested in Zhengye Biotechnology Holding Limited Ordinary Shares in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.94K |
| 2 |
Morgan Stanley
New York
|
+$247 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5 |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $6.94K | +$6.94K | +1,289 | New |
|
|
2
Morgan Stanley
New York
| $247 | +$247 | +46 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $5 | +$5 | +1 | New |
|